Endometrial expression of T-cell immunoreceptor with Ig and ITIM domains and cluster of differentiation 155: A case-control study of a novel immunomodulatory axis in endometriosis
International Journal of Reproductive BioMedicine (IJRM) · 17.05.2026 · 24 (3)
DOI: 10.18502/ijrm.v24i3.21118 ↗Kurz gefasst
Fall-Kontroll-Studie in der Zeitschrift International Journal of Reproductive BioMedicine (IJRM), online erschienen am 17.05.2026. Verfasst von Reyhane Nematollahi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Endometriosis is a chronic inflammatory disorder affecting about 10% of females in their reproductive years, characterized by endometrial tissue growing outside the uterus. Immune checkpoints play a crucial role in regulating the immune system and preserving homeostasis. T-cell immunoreceptor with immunoglobulin and immunoreceptor tyrosine-based inhibitory motif domains (TIGIT), a newly discovered immune checkpoint, interacts with its ligand, cluster of differentiation 155 (CD155), to exert inhibitory effects on immune responses.
Objective
Though numerous studies have explored the immunological profile in endometriosis cases, limited information exists about the potential role of TIGIT/CD155 interaction. Materials and Methods: This case-control study aimed to investigate the expression levels of TIGIT and CD155 genes in ectopic and eutopic tissues of 20 women diagnosed with endometriosis by a gynecologist with laparoscopy compared to the endometrium of 20 women without endometriosis, using real-time polymerase chain reaction.
Results
Results showed that both TIGIT and CD155 gene expressions were significantly higher in ectopic endometrial tissues (p < 0.0001). CD155 is also upregulated in the eutopic endometrium of cases (p < 0.0001). However, no significant difference in TIGIT expression was observed between eutopic endometrium of cases and controls (p = 0.49).
Conclusion
These findings suggest an upregulation of the TIGIT/CD155 pathway in endometriosis, indicating its potential role in the disease’s pathogenesis. Further research is necessary to fully understand this signaling pathway and explore its viability as a biomarker for diagnosis and immunotherapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Immunology, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
- Abortion Research Center, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
- Department of Immunology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Zitieren
APA
Nematollahi, R., Samadi, M., Montazeri, F., Kalantar, S. M., & Shams, A. (2026). Endometrial expression of T-cell immunoreceptor with Ig and ITIM domains and cluster of differentiation 155: A case-control study of a novel immunomodulatory axis in endometriosis. International Journal of Reproductive BioMedicine (IJRM), 24(3). https://doi.org/10.18502/ijrm.v24i3.21118
Vancouver
Nematollahi R, Samadi M, Montazeri F, Kalantar SM, Shams A. Endometrial expression of T-cell immunoreceptor with Ig and ITIM domains and cluster of differentiation 155: A case-control study of a novel immunomodulatory axis in endometriosis. International Journal of Reproductive BioMedicine (IJRM). 2026;24(3). doi:10.18502/ijrm.v24i3.21118
BibTeX
@article{Nematollahi2026,
author = {Nematollahi, Reyhane and Samadi, Morteza and Montazeri, Fateme and Kalantar, Seyed Mehdi and Shams, Ali},
title = {Endometrial expression of T-cell immunoreceptor with Ig and ITIM domains and cluster of differentiation 155: A case-control study of a novel immunomodulatory axis in endometriosis},
journal = {International Journal of Reproductive BioMedicine (IJRM)},
year = {2026},
volume = {24},
number = {3},
doi = {10.18502/ijrm.v24i3.21118}
}
EUVIMED